Utility of circulating tumor DNA in monitoring treatment response to immune checkpoint inhibitors in patients with advanced genitourinary cancers.

被引：0
|
作者：
Jang, Albert
Jaeger, Ellen B.
Rauterkus, Grant
Lieberman, Alexandra
Huang, Minqi
Lanka, Sree M.
Sudhaman, Sumedha
Mahmood, Tamara
Pajak, Natalia
Calhoun, Mark
Tlemcani, Kaoutar
ElNaggar, Adam
Liu, Minetta
Lewis, Brian E.
Layton, Jodi Lyn
Sartor, A. Oliver
Barata, Pedro C.
机构：
[1] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[2] Tulane Univ, New Orleans, LA 70118 USA
[3] Tulane Canc Ctr, New Orleans, LA USA
[4] Natera Inc, Austin, TX USA
[5] Natera Inc, San Carlos, CA USA
[6] Univ Hosp Seidman Canc Ctr, Dept Internal Med, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
721
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Malignancies
    Jang, Albert
    Lanka, Sree M.
    Jaeger, Ellen B.
    Lieberman, Alexandra
    Huang, Minqi
    Sartor, A. Oliver
    Mendiratta, Prateek
    Brown, Jason R.
    Garcia, Jorge A.
    Farmer, Tiffany
    Sudhaman, Sumedha
    Mahmood, Tamara
    Pajak, Natalia
    Calhoun, Mark
    Dutta, Punashi
    Elnaggar, Adam
    Liu, Minetta C.
    Barata, Pedro C.
    JCO PRECISION ONCOLOGY, 2023, 7
  • [2] PROSPECTIVE EVALUATION OF CIRCULATING TUMOR DNA (CTDNA) IN DETECTING EARLY PROGRESSION ON IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH ADVANCED GENITOURINARY CANCERS
    Jang, Albert
    Jaeger, Ellen
    Rauterkus, Grant
    Liberman, Alex
    Sussman, Isabelle
    Light, Malcolm
    Huang, Minqi
    Manogue, Charlotte
    Caputo, Sydney
    Miller, Patrick
    Lewis, Brian
    Layton, Jodi
    Sartor, Oliver
    Burgess, Earle
    Farmer, Tiffany
    Widden, Hayley
    Flippen, Carrie
    Aleshin, Alexey
    Grigg, Claud
    Barata, Pedro
    JOURNAL OF UROLOGY, 2022, 207 (05): : E165 - E166
  • [3] Clinical utility of circulating tumor DNA in patients with head and neck cancers.
    Onyshchenko, Mykola
    Rock, Adam
    Sila, Chad
    LaBarbera, Katie
    Rathore, Richa
    Ji, Ping
    McPhaul, Laron
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18003 - E18003
  • [4] HYPOALBUMINEMIA EARLY IN TREATMENT HINDERS BENEFIT FROM IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH ADVANCED CANCERS.
    Guo, Y.
    Kulp, S.
    Mace, T.
    Coss, C.
    Phelps, M.
    Owen, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S63 - S64
  • [5] Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors
    van der Leest, Paul
    Hiddinga, Birgitta
    Miedema, Anneke
    Aguirre Azpurua, Maria L.
    Rifaela, Naomi
    ter Elst, Arja
    Timens, Wim
    Groen, Harry J. M.
    van Kempen, Leon C.
    Hiltermann, T. Jeroen N.
    Schuuring, Ed
    MOLECULAR ONCOLOGY, 2021, 15 (11) : 2910 - 2922
  • [6] Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer
    Tolmeijer, Sofie H.
    van Wilpe, Sandra
    Geerlings, Maartje J.
    von Rhein, Daniel
    Smilde, Tineke J.
    Kloots, Iris S. H.
    Westdorp, Harm
    Coskunturk, Mustafa
    Oving, Irma M.
    van Ipenburg, Jolique A.
    van der Heijden, Antoine G.
    Hofste, Tom
    Weiss, Marjan M.
    Schalken, Jack A.
    Gerritsen, Winald R.
    Ligtenberg, Marjolijn J. L.
    Mehra, Niven
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (02): : 282 - 291
  • [7] Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade
    Zhang, Qu
    Luo, Jia
    Wu, Song
    Si, Han
    Gao, Chen
    Xu, Wenjing
    Abdullah, Shaad E.
    Higgs, Brandon W.
    Dennis, Phillip A.
    van der Heijden, Michiel S.
    Segal, Neil H.
    Chaft, Jamie E.
    Hembrough, Todd
    Barrett, J. Carl
    Hellmann, Matthew D.
    CANCER DISCOVERY, 2020, 10 (12) : 1842 - 1853
  • [8] Utility of circulating tumor DNA as a tool to detect minimal residual disease in patients with metastatic cancer and durable response following treatment with immune checkpoint inhibitors
    Afzal, Muhammad Zubair
    Corea-Dilbert, Flanklin E.
    Wankel, Bret
    Palmer, John P.
    Pirruccello, Jonathan P.
    Kale, Soham
    Sharma, Aditya
    Lu, Ziyao
    Ibrahim, Samer
    Cao, Yuanzhen
    Sarwar, Tayyaba
    Shirai, Keisuke
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Treatment of advanced urogenital cancers with immune checkpoint inhibitors
    Jung, Eun Hee
    Kim, Se Hyun
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (05): : 349 - 357
  • [10] Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers
    Okuma, Hitomi Sumiyoshi
    Yonemori, Kan
    Kojima, Yuki
    Tanioka, Maki
    Sudo, Kazuki
    Noguchi, Emi
    Hijioka, Susumu
    Wakakuwa, Keiko
    Kato, Ken
    Hirakawa, Akihiro
    Kuchiba, Aya
    Kubo, Takashi
    Ichikawa, Hitoshi
    Yoshida, Akihiko
    Yatabe, Yasushi
    Nakamura, Kenichi
    Mano, Hiroyuki
    Yamamoto, Noboru
    Fujiwara, Yasuhiro
    FRONTIERS IN ONCOLOGY, 2021, 11
12345